Colonial River Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$523K Sell
21,713
-2,619
-11% -$68.5K 0.15% 122
2026
Q1
$683K Sell
24,332
-1,929
-7% -$51.4K 0.24% 86
2025
Q4
$654K Sell
26,261
-15
-0.1% -$378 0.23% 88
2025
Q3
$670K Sell
26,276
-70
-0.3% -$1.73K 0.25% 88
2025
Q2
$679K Buy
26,346
+3,626
+16% +$84.6K 0.29% 74
2025
Q1
$576K Sell
22,720
-4,963
-18% -$130K 0.32% 75
2024
Q4
$734K Sell
27,683
-4,880
-15% -$132K 0.36% 70
2024
Q3
$942K Sell
32,563
-12,954
-28% -$378K 0.47% 52
2024
Q2
$1.27M Buy
45,517
+3,372
+8% +$92.8K 0.69% 44
2024
Q1
$1.17M Buy
42,145
+3,977
+10% +$110K 0.66% 42
2023
Q4
$1.1M Buy
38,168
+9,572
+33% +$289K 0.65% 44
2023
Q3
$949K Buy
28,596
+19,314
+208% +$683K 0.62% 55
2023
Q2
$340K Sell
9,282
-23,868
-72% -$929K 0.22% 121
2023
Q1
$1.35M Buy
33,150
+3,906
+13% +$169K 0.79% 38
2022
Q4
$1.5M Buy
29,244
+6,829
+30% +$327K 0.96% 30
2022
Q3
$981K Sell
22,415
-413
-2% -$20.1K 0.68% 42
2022
Q2
$1.2M Buy
22,828
+1,840
+9% +$93.8K 0.78% 37
2022
Q1
$1.09M Buy
20,988
+7,206
+52% +$374K 0.63% 43
2021
Q4
$814K Buy
+13,782
New +$683K 0.44% 68
2021
Q3
Sell
-12,266
Closed -$480K 141
2021
Q2
$480K Buy
12,266
+332
+3% +$12.9K 0.34% 83
2021
Q1
$432K Sell
11,934
-314
-3% -$11.1K 0.35% 83
2020
Q4
$428 Buy
+12,248
New +$449K 0.19% 80

Other funds holding PFE

Colonial River Investments's PFE Position: Q2 2026 in Review

Colonial River Investments reduced its Pfizer (PFE) stake by 11% in Q2 2026, selling an estimated $68.5K and leaving 21,713 shares worth $523K. The position accounts for 0.15% of the portfolio, ranked #122.

Colonial River Investments first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.5M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Colonial River Investments held 21,713 shares of Pfizer worth $523K as of Q2 2026.
  • Colonial River Investments sold 2,619 Pfizer shares in Q2 2026, an estimated $68.5K.
  • Pfizer made up 0.15% of Colonial River Investments's portfolio in Q2 2026, its #122 holding.
  • Colonial River Investments first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • Colonial River Investments's Pfizer position peaked at $1.5M in Q4 2022.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Colonial River Investments's 13F filing for Q2 2026, filed 24 Jul 2026.